Skip to main content

Table 1 Comparison of clinical information between NCI and CIgroups at baseline

From: Persisting cognitive impairment predicts functional dependence at 1 year after stroke and transient ischemic attack: a longitudinal, cohort study

Baseline Variables

NCI group

(n = 857)

CI group

(n = 818)

P value

Gender (male, n,%)

654(76.31)

583(71.27)

0.019*

Average age (years, mean ± SD)

58.37 ± 10.80

62.79 ± 9.59

< 0.001**

Body mass index (kg/m2, mean ± SD)

25.08 ± 3.15

25.11 ± 3.24

0.88

Risk factors

 Diabetes (n, %)

284(33.14)

257(31.42)

0.45

 Hypertension (n, %)

659(76.90)

603(73.72)

0.13

 Lipid metabolism disorders (n, %)

385(44.92)

352(43.03)

0.44

 Atrial fibrillation (n, %)

34(3.97)

34(4.16)

0.84

 Current or previous smoking (n, %)

324(38.04)

298(36.43)

0.50

Previous mRS [scores, median (IQR)])

0.00(1.00)

0.00 (1.00)

0.24

Previous stroke (n, %)

148(17.27)

215(26.28)

< 0.0001**

NIHSS at baseline [scores, median (IQR)]

2.00 (2.00)

2.00 (2.00)

0.10

Neuropsychiatric symptom at 2 weeks (n, %)

 PSQI > 5

352(41.07)

384(46.94)

0.016*

 ESS > 10

100(11.71)

92(11.27)

0.78

 PHQ-9 > 9

46(5.40)

75(9.26)

0.0025**

 GAD-7 > 9

36(4.21)

48(5.90)

0.11

Stroke subtype for TOAST (n,%)

  

0.02*

 large artery atherosclerosis

169(19.72)

211(25.79)

 

 cardiogenic embolism

40(4.67)

41(5.01)

 

 small artery occlusion

266(31.04)

218(26.65)

 

 Other/Unknown

382(44.57)

348(42.54)

 

Acute infarction type (n,%)

  

0.0010*

 Single infarction

401(46.79)

338(41.32)

 

 Multiple infarction

294(34.31)

347(42.42)

 

 Simple watershed infarction

10(1.17)

18(2.20)

 

 No infarction

152(17.74)

115(14.06)

 

Intracranial atherosclerotic stenosis (ICAS) (n,%)

154(28.62)

208(36.30)

0.006**

Intravenous thrombolysis (n,%)

56(6.53)

42(5.13)

0.22

Dual antiplatelet therapy (n,%)

368(49.60)

406(54.79)

0.045*

Secondary prevention of stroke at 2 weeks (n,%)

 Antiplatelet or anticoagulant therapy

841(98.13)

800(97.80)

0.63

 Antihypertensive therapy

467(54.49)

439(53.67)

0.73

 Lipid-lowering therapy

813(94.87)

786(96.09)

0.23

 Hypoglycemic therapy

213(24.85)

205(25.06)

0.92

  1. mRS modified Rankin Scale, NIHSS National Institutes of Health Stroke Scale, PSQI Pittsburgh Sleep Quality Index, ESS Epworth Sleeping Scale, GAD-7 Anxiety Disorder-7, PHQ-9 Patient Health Questionnaire-9. *<0.05;**<0.01